Current Cancer Drug Targets
Overview
Current Cancer Drug Targets is a peer-reviewed journal that focuses on the latest advancements in the field of cancer drug discovery and development. It provides a platform for researchers and clinicians to share their findings on novel drug targets, therapeutic strategies, and emerging technologies for the treatment of various types of cancer. The journal aims to facilitate the translation of scientific knowledge into effective cancer therapies, ultimately improving patient outcomes.
Details
Details
Abbr.
Curr Cancer Drug Targets
Publisher
Bentham Science Publishers
Start
2001
End
Continuing
Frequency
Eleven issues a year, 2019-
p-ISSN
1568-0096
e-ISSN
1873-5576
Country
Netherlands
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 2960
103
SJR / Ranks: 6911
650
CiteScore / Ranks: 4260
5.60
JIF / Ranks: 3481
3.0
Recent Articles
1.
Al Ayidh A, Abbas M, Parayangat M, Ijyas T
Curr Cancer Drug Targets
. 2025 Mar;
PMID: 40077824
The development of targeted drug delivery systems has transformed modern medicine, offering novel approaches to improve the efficacy and safety of therapeutic agents. Nanomaterials, due to their unique physicochemical properties,...
2.
Shahzadi S, Yasir M, Kloczkowski A, Hassan M
Curr Cancer Drug Targets
. 2025 Mar;
PMID: 40070334
Background: Prior research has demonstrated that proteins play a significant role in the prognosis and treatments of various sarcomas, including Ewing sarcoma through the interplay of downstream signaling cascades. However,...
3.
Raeisi E, Heidari-Soureshjani S, Mt Sherwin C, Lemoigne Y, -Nafchi H
Curr Cancer Drug Targets
. 2025 Mar;
PMID: 40059427
Introduction/objective: Nano-curcumins (Nano-CUR) improve solubility, bio-availability, and stability of the release of CUR into the body. In this systematic review, we aim to investigate different CUR nanoformulations' in targeting radiosensitizing...
4.
Wang S, Zheng B, Yang J, Zhang J
Curr Cancer Drug Targets
. 2025 Mar;
PMID: 40051366
Background: Historically, there has been a lack of focus on the mortality rates of individuals with both diabetes and Bladder Bancer (BC). Our study aimed to identify the risk factors...
5.
Wang K, He Q, Jiang X, Ma Y, Wang T, Zhou H, et al.
Curr Cancer Drug Targets
. 2025 Mar;
PMID: 40051365
The ubiquitin-proteasome system is a fundamental regulatory mechanism that governs protein stability and intracellular signaling in eukaryotic cells. This system relies on a coordinated cascade of enzymatic activities involving activating...
6.
Zheng J, Chen Y, Peng X, Zheng W, Zhang Y, Hei F, et al.
Curr Cancer Drug Targets
. 2025 Mar;
PMID: 40051364
Among the Poly(ADP-ribose) Polymerase (PARP) family in mammals, PARP1 is the first identified and well-studied member that plays a critical role in DNA damage repair and has been proven to...
7.
Kumar R, Maleme J, Kumar S, Sudhakar K, R Telange D, Maiti O, et al.
Curr Cancer Drug Targets
. 2025 Mar;
PMID: 40051363
Biotechnology has paved the way for the development of cancer therapeutics that harness biological systems. Cancer immunotherapy (CI) is a pivotal and swiftly progressing therapeutic modality, alongside surgical intervention, cytotoxic...
8.
Li H, Yu Q, Song J, Ding H, Chen Y, Jin Y, et al.
Curr Cancer Drug Targets
. 2025 Mar;
PMID: 40045858
Introduction: Breast Cancer (BC) is one of the most prevalent malignant tumors in women. The incidence of estrogen receptor-positive (ER+) breast cancer is as high as 70%, and it is...
9.
Barjasteh A, Abdolamir A, Al-Asady A, Latifi H, Avan A, Khazaei M, et al.
Curr Cancer Drug Targets
. 2025 Mar;
PMID: 40033590
Recent investigations have indicated that circRNAs (circular RNAs), a novel member of the Noncoding RNA family, are a crucial genetic factor in Colorectal Cancer (CRC), development. These circRNAs have a...
10.
Mohareb R, Gamaan M, Megally Abdo N, Mikhail I
Curr Cancer Drug Targets
. 2025 Mar;
PMID: 40033500
Background: Quinoline derivatives, often incorporating other heterocyclic structures, have shown a wide range of therapeutic potential, especially in the treatment of cancer. These compounds have demonstrated significant anticancer activity against...